+

WO2000061066A2 - Agent cosmetique et son utilisation - Google Patents

Agent cosmetique et son utilisation Download PDF

Info

Publication number
WO2000061066A2
WO2000061066A2 PCT/EP2000/003195 EP0003195W WO0061066A2 WO 2000061066 A2 WO2000061066 A2 WO 2000061066A2 EP 0003195 W EP0003195 W EP 0003195W WO 0061066 A2 WO0061066 A2 WO 0061066A2
Authority
WO
WIPO (PCT)
Prior art keywords
acid
group
composition according
alkyl
fatty
Prior art date
Application number
PCT/EP2000/003195
Other languages
German (de)
English (en)
Other versions
WO2000061066A3 (fr
Inventor
Jens Meyer
Dieter Goddinger
Winfried Seidel
Original Assignee
Hans Schwarzkopf Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Schwarzkopf Gmbh & Co. Kg filed Critical Hans Schwarzkopf Gmbh & Co. Kg
Priority to AU41170/00A priority Critical patent/AU4117000A/en
Publication of WO2000061066A2 publication Critical patent/WO2000061066A2/fr
Publication of WO2000061066A3 publication Critical patent/WO2000061066A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/34—Higher-molecular-weight carboxylic acid esters
    • C09K23/36—Esters of polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents

Definitions

  • the invention relates to aqueous cosmetic compositions for the treatment of hair or skin, which are formulated on a mild surfactant basis, and to the use of these compositions for cleaning hair and skin.
  • compositions with certain mild surfactants in combination with special care substances are both extremely mild and have excellent product performance.
  • the care effects that can be achieved by using these agents on the hair clearly exceed those obtained when these care agents are used in agents based on other surfactants.
  • the invention therefore relates to aqueous cosmetic compositions for treating the hair or the skin on a mild surfactant base, which contain as surfactant at least one ester of a hydroxy-substituted bicarbonic acid or tricarboxylic acid (A) with the general formula (I),
  • YH or -OH is, provided that X is when X is -CH 2 COOR, R, R "and R 2 independently of one another are a hydrogen atom, an alkali metal or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic Base or a radical Z which is derived from a polyhydroxylated organic compound selected from the group consisting of etherified (C 6 -C 8 ) -alkyl polysaccharides with 1 to 6 monomeric saccharide units and etherified aliphatic (C 6 -C, 6 ) - .
  • Hydroxyalkyl polyols having 2 to 16 hydroxyl radicals is selected, on the condition that at least one of the groups R, R 1 or R 2 is a radical Z, and at least one care substance (B) selected from
  • Protein hydrolyzates and their derivatives (B1), quaternary ammonium compounds (B2), insoluble silicone compounds (B3) and synthetic or natural oil, fat or wax components (B4).
  • the compounds of formula (I) are, for example, from European Patent EP-B1-0 258 814 and from the articles by N. Bums, Drug Cosmet. Ind. 160 (3), 42 (1997) and T. Verzotti et al., Cosmetic News XX-112, 29 (1997).
  • this prior art does not provide any indication of the agents according to the invention.
  • R, R 1 and R 2 preferably represent alkali metal cations, in particular the sodium ion, alkaline earth metal cations, in particular the magnesium ion, and the ammonium ion.
  • the group Z is preferably an etherified (C 6 -C 18 ) alkyl polysaccharide.
  • Group Z preferably contains glucose as the saccharide.
  • C 6 -C 6 -alkyl groups in particular are used as alkyl groups, the choice of unbranched saturated groups being preferred.
  • the alkyl groups can, however, also be mixtures which are obtained when natural fats and oils are processed. Mixtures consisting essentially of C 8 -C 10 alkyl groups, C I2 -C 14 alkyl groups or
  • C 8 -C 16 alkyl groups can be preferred according to the invention.
  • a mixture of alkyl groups such as is obtained when coconut oil is processed, is very particularly preferred.
  • Group Z contains 1 to 6 monomeric saccharide units. According to a preferred embodiment, group Z contains 2 to 6 glucose units. However, it may also be preferred to use groups Z with 1.2 to 3, in particular 1.3 to 2, glucose units. It should be noted that mixtures always arise in the synthesis, and these numerical values are derived from the stoichiometric ratio of the starting substances fatty alcohol and saccharide.
  • the compounds according to formula (I) are derivatives of citric acid, tartaric acid or malic acid. Such compounds which are derivatives of citric acid and in particular tartaric acid are preferred according to the invention.
  • the agents according to the invention can of course also contain more than one surfactant (A) of the formula (I).
  • the agents according to the invention preferably contain the compounds of formula (I) in amounts of 0.5 to 8.0% by weight, particularly preferably in amounts of 1 to 5% by weight and in particular in amounts of about 2 to 3% by weight. -%, each based on the total mean.
  • the agents according to the invention contain a special care substance (B).
  • the care substance (B) is selected from protein hydrolyzates and their derivatives (B1).
  • Protein hydrolyzates are product mixtures that are obtained by acidic, basic or enzymatically catalyzed breakdown of proteins (proteins). The hydrolysis of proteins usually results in a protein hydrolyzate with a molecular weight distribution of approximately 100 daltons up to several thousand daltons.
  • protein hydrolyzates of both vegetable and animal origin can be used.
  • Animal protein hydrolyzates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolyzates, which can also be in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois ® (Interorgana), Collapuron ® (Cognis), Nutrilan ® (Cognis), Gelita-Sol ® (Deutsche Gelatine Fabriken Stoess & Co), Lexein ® (Inolex) and Kerasol ® (Croda) sold.
  • protein hydrolysates of plant origin e.g. B. soy, almond, rice, pea, potato and wheat protein hydrolyzates.
  • Such products are available, for example, under the trademarks Gluadin ® (Cognis), DiaMin ® (Diamalt), Lexein ® (Inolex) and Crotein ® (Croda).
  • amino acid mixtures obtained in some other way or individual amino acids such as, for example, arginine, lysine, histidine or pyrroglutamic acid may also be used in their place.
  • Derivatives of protein hydrolyzates preferred according to the invention are cationized protein hydrolyzates and protein hydrolyzate-fatty acid condensation products.
  • the underlying protein hydrolyzate can be obtained from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, from marine life forms, for example from fish collagen or algae, or from biotechnologically obtained protein hydrolyzates.
  • This protein hydrolyzate can be obtained from the corresponding proteins by chemical, in particular alkaline or acidic hydrolysis, by enzymatic hydrolysis and or a combination of both types of hydrolysis.
  • Preferred cationic protein hydrolyzates are those whose underlying protein content has a molecular weight of 100 to 25,000 Daltons, preferably 250 to 5000 Daltons.
  • Cationic protein hydrolyzates also include quaternized amino acids and their mixtures.
  • the quaternization of the protein hydrolyzates or the amino acids is often carried out using quaternary ammonium salts such as, for example, N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • the cationic protein hydrolyzates can also be further derivatized.
  • Typical examples of the cationic protein hydrolyzates and derivatives according to the invention are those under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook" (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 * Street, NW, Suite 300 , Washington, DC 20036-4702) and commercially available products: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Hydrolyzed Silk, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Silk Amino Acids, Hydroxypropyl Arginine Lauryl
  • Protein hydrolyzate fatty acid condensates are for example sold under the names Lamepon ® (Cognis), Gluadin ® (Cognis), Lexein ® (Inolex), Crolastin ® (Croda) or Crotein ® (Croda). Lauryl acid, oleic acid, abietic acid and undecylenic acid and natural fatty acid mixtures, such as coconut oil fatty acid, are preferred fatty acid components.
  • the protein hydrolyzates and their derivatives are contained in the agents according to the invention in amounts of 0.01-10% by weight, based on the total agent. Amounts of 0.1 to 5% by weight, in particular 0.1 to 3% by weight, are very particularly preferred.
  • the care substance (B) is a quaternary ammonium compound (B2).
  • quaternary ammonium compounds are understood to mean both those compounds which permanently have a quaternary ammonium group and also tertiary amines which, depending on the medium and pH, can be present as quaternary ammonium salts.
  • Quaternary ammonium compounds preferred according to the invention are cationic surfactants of the quaternary ammonium salt, esterquat and alkylamidoamine type.
  • Preferred quaternary ammonium salts are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g. B. cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the compounds known under the INCI names Quaternium-27 and Quaternium-83 compounds imidazolium.
  • alkyltrimethylammonium chlorides dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are sold, for example, under the trademarks Stepantex ® , Dehyquart ® and Armocare ® .
  • alkylamidoamines are usually produced by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines. This is assumed by a compound from this group of substances which is particularly suitable according to the invention the name Tegoamid ® S 18 commercially available stearamidopropyl-dimethylamine.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • the care substances (B2) are preferably present in the agents according to the invention in amounts of 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5% by weight are particularly preferred.
  • the care substance (B) is an insoluble silicone compound (B3).
  • insoluble are those silicone compounds which are present in the respective water surfactant base of the agent, ie in the mixture of the components water and surfactants in the appropriate amounts, to less than 0.1% by weight, based on these Water / surfactant base, are soluble.
  • Silicone compounds which can be used according to the invention are, for example, dialkyl and alkylarylsiloxanes, such as, for example, dimethylpolysiloxane and
  • Methylphenylpolysiloxane as well as their hydroxy-terminated, alkoxylated and quaternized analogues.
  • silicones are the products sold by Dow Corning under the names DC 190, DC 200 and DC 1401 and the commercial products DC 344 and DC 345 from Dow Corning, Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning ® 929 emulsion (containing a hydroxylamino-modified silicone, which is also known as amodimethicone), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th.
  • Silicone compounds (B3) preferred according to the invention are dialkylsiloxanes, dialkylsiloxanes with terminal hydroxyl groups, alkylarylsiloxanes and siloxanes with amino groups.
  • the silicone compounds (B3) are preferably present in the agents according to the invention in amounts of 0.01-10% by weight, based on the total agent. Amounts of 0.05-10, in particular 0.05-3,% by weight are particularly preferred.
  • the care substance (B) is a synthetic or natural oil, fat or wax component (B4).
  • component (B4) is selected from fatty alcohols and fatty acids.
  • Saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 , preferably C 10 -C 22 and very particularly preferably C 12 -C 22 carbon atoms can be used as fatty alcohols.
  • the fatty alcohols are derived from preferably natural fatty acids, and it can usually be assumed that they are obtained from the esters of the fatty acids by reduction.
  • those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rape oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® , for example Stenol ® 1618 or Lanette ® , for example Lanette ® O or Lorol ® , e.g.
  • the invention also wool wax alcohols, as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used.
  • the fatty alcohols are used in amounts of 0.1-20% by weight, based on the entire preparation, preferably in amounts of 0.1-10% by weight.
  • Linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms can be used as fatty acids.
  • Fatty acids with 10-22 carbon atoms are preferred.
  • isostearic as the commercial products Emersol ® 871 and Emersol ® 875
  • isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, galeoachenic acid, galeoacheneic acid, elenachearic acid and erucic acid and their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxosynthesis or in the dimerization of unsaturated fatty acids.
  • the fatty acid cuts which are obtainable from coconut oil or palm oil are usually particularly preferred; the use of stearic acid is generally particularly preferred.
  • the amount used is 0.1-15% by weight, based on the total agent. In a preferred embodiment, the amount is 0.5-10% by weight, with amounts of 1-5% by weight being very particularly advantageous.
  • component (B4) is selected from mineral oils, paraffin and isoparaffin oils, synthetic hydrocarbons, dialkyl ethers and dialkyl carbonates.
  • An inventively employable synthetic hydrocarbon for example, l the available as commercial products Compound E, 3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ® S)
  • Dialkyl ethers which can be used according to the invention are in particular di-n-alkyl ethers with a total of between 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether, di- n-undecyl ether, di-n-dodecyl ether, n-hexyl-n-octyl ether, n-octyl-n-decyl ether, n-decyl-n-undecyl ether, n-undecyl-n-dodecyl ether and n-hexyl-n-undecyl ether as well Di-tert-butyl ether, di-isopentyl ether, di-3-ethyldecyl ether, tert-butyl-
  • dialkyl carbonates which can be used according to the invention are obtainable by complete transesterification of low molecular weight dialkyl carbonates, for example dimethyl carbonate or diethyl carbonate, with, for example, fatty alcohols having 6 to 22 carbon atoms or their ethylene oxide and / or propylene oxide addition products.
  • dialkyl carbonates for example dimethyl carbonate or diethyl carbonate
  • fatty alcohols having 6 to 22 carbon atoms or their ethylene oxide and / or propylene oxide addition products.
  • di-n-octyl carbonate which is obtainable by the transesterification of n-octanol (capryl alcohol), and is sold under the trade name Cetiol ® CC.
  • dialkyl carbonates which can be used according to the invention have branched alkyl groups.
  • a commercially available product of this type is e.g. di- (2-hexyldecyl) carbonate, which is obtained by transesterification of diethyl carbonate with 2-hexyl-decanol, a Guerbet alcohol, and is also referred to as "Guerbet carbonate”.
  • Another preferred dialkyl carbonate with branched alkyl chains is the di- (2-ethylhexyl) carbonate.
  • dialkyl carbonates preferred according to the invention is accessible through the complete transesterification of low molecular weight dialkyl carbonates, for example dimethyl carbonate or diethyl carbonate, with the ethylene oxide and or propylene oxide addition products of fatty alcohols.
  • ethoxylated or propoxylated fatty alcohols are available under various trade names.
  • Ethoxylated C g . 10 fatty alcohols are, for example under the name of Lorol ®, ethoxylated C 12th 14 fatty alcohols, for example under the name Dehydol ® and ethoxylated C 16 . 18 fatty alcohols, for example under the name Mergital ® from Cognis.
  • the preferred addition products have a degree of ethoxylation of 2-7.
  • particularly preferred dialkyl carbonates are accessible from the transesterification with Dehydol ® products.
  • compounds of the 1,3-dioxolan-2-one type which can be regarded as the cyclic carbonate of a vicinal glycol, can also be used according to the invention.
  • Such compounds are obtainable by transesterifying dimethyl carbonate or diethyl carbonate with, for example, 1,2-propylene glycol or glycerin.
  • cyclic dialkyl carbonates are 4-methyl-l, 3-dioxolan-2-one, and 4-hydroxymethyl-l, 3-dioxolan-2- on.
  • waxes • solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, walrus, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes made of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • oils in quantities of at least 0.5% by weight, based on the total agent.
  • oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, orange oil, wheat germ oil, peach seed oil and the liquid components of coconut oil.
  • triglyceride oils such as the liquid portions of beef tallow and synthetic triglyceride oils are also suitable.
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate as well as diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate, propylene glycol di (2 -ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate and neopentyl glycol dicaprylate,
  • the amount of care substances (B4) used is 0.1-50% by weight, based on the total composition, preferably 0.1-20% by weight and particularly preferably 0.1-15% by weight.
  • care substances (B4) in the form of aqueous dispersions.
  • An example of such a dispersion is the commercial product Lamesoft ® PW 45.
  • the agents according to the invention contain water as the third mandatory component.
  • the pH of these preparations can in principle be between 2 and 11. It is preferably between 2 and 9, in particular between 3 and 7, values from 4 to 5.5 being particularly preferred.
  • Virtually any acid or base that can be used for cosmetic purposes can be used to adjust this pH.
  • Food acids are usually used as acids.
  • Edible acids are understood to mean those acids that are ingested as part of normal food intake and have positive effects on the human organism. Edible acids are, for example, acetic acid, lactic acid, tartaric acid, citric acid, malic acid, ascorbic acid and gluconic acid. In the context of the invention, the use of citric acid and lactic acid is particularly preferred.
  • Preferred bases are ammonia, alkali metal hydroxides, triethanolamine and N, N, N ', N'-tetrakis (2-hydroxypropyl) ethylenediamine.
  • the cosmetic agent is not subject to any restrictions.
  • the mildness of the preparations according to the invention is particularly important in agents for treating the hair and skin, in particular for cleaning and maintaining the hair and skin.
  • the agent according to the invention is a hair cleanser (shampoo), a shower bath, a foam bath or a liquid soap. Shampoos and shower baths are preferred representatives of this embodiment.
  • These agents can contain other ingredients known for such preparations.
  • the shampoos, shower baths, foam baths and liquid soaps according to the invention preferably contain at least one further surfactant as a cleaning component.
  • This is selected in particular from the group of anionic, ampholytic, - weatherionic and nonionic surfactants.
  • Suitable anionic surfactants in preparations according to the invention are all anionic surface-active substances suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 8 to 30 carbon atoms.
  • the molecule can contain glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups.
  • suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts with 2 to 4 carbon atoms in the alkanol group,
  • Alkyl group with 8 to 30 carbon atoms and x 0 or 1 to 16,
  • Atoms in the alkyl group and 1 to 6 oxyethyl groups linear alkanesulfonates with 8 to 24 C atoms, linear alpha-olefin sulfonates with 8 to 24 C atoms,
  • Alpha-sulfofatty acid methyl esters of fatty acids with 8 to 30 carbon atoms are alpha-sulfofatty acids methyl esters of fatty acids with 8 to 30 carbon atoms,
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group with 8 to 30 C atoms and x 0 or 1 to 12,
  • Esters of tartaric acid and citric acid with alcohols the addition products of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols with 8 to 22
  • R is preferred for an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
  • R ' for hydrogen, a radical (CH 2 CH 2 O) n R or X, n for numbers from 1 to 10 and X for hydrogen, an alkali or alkaline earth metal or NR'R 2 R 3 R 4 , with R 1 to R 4 independently of one another being hydrogen or a C to C 4 hydrocarbon radical, sulfated fatty acid alkylene glycol esters of the formula RCO (AlkO) n SO 3 M, in which RCO- for a linear or branched, aliphatic, saturated and or unsaturated Acyl radical with 6 to 22 carbon atoms, alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3 , n for numbers from 0.5 to 5 and M for a cation, as described in DE OS 197 36 906.5 are described,
  • Typical examples of monoglyceride (ether) sulfates are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride, as well as their ethylene oxide adducts with sulfuric acid dioxide or their sodium sulfate form.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids with 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule and sulfosuccinic acid and dialkyl esters with 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid mono-alkylpolyoxyethyl ester with 8 up to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one -COO w
  • zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinates, for example that lo
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known under the INCI name Cocamidopropyl Betaine.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C 8 -C 24 -alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and are capable of forming internal salts .
  • suitable ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N- alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-
  • Alkyltaurines N-alkyl sarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids, each with about 8 to 24 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylamino propionate and C 12 -C 18 acyl sarcosine.
  • Nonionic surfactants contain z as a hydrophilic group.
  • B a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group.
  • Such connections are, for example
  • Adducts of 5 to 60 moles of ethylene oxide with castor oil and hardened castor oil Adducts of 5 to 60 moles of ethylene oxide with castor oil and hardened castor oil
  • RCO- (OCH 2 CHR ') w OR " Alkoxylated fatty acid alkyl esters of the formula RCO- (OCH 2 CHR ') w OR ", in which RCO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R' for hydrogen or methyl, R 'for linear or branched alkyl radicals with 1 to 4 carbon atoms and w represents numbers from 1 to 20,
  • Sorbitan fatty acid esters and addition products of ethylene oxide with sorbitan fatty acid esters such as, for example, the polysorbates
  • alkyl polyglycosides according to the general formula RO- (Z) x where R is alkyl, Z is sugar and x is the number of sugar units.
  • the alkyl polyglycosides which can be used according to the invention may contain only one specific alkyl radical R. Usually, however, these compounds are made from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the respective working up of these compounds.
  • nonionic surfactants are alkyl polyglycosides in which R essentially from C 8 and C 10 alkyl groups,
  • Any mono- or oligosaccharides can be used as sugar building block Z.
  • Sugar with 5 or 6 carbon atoms and the corresponding oligosaccharides are usually used.
  • sugars are glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, old rose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar units are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • alkyl polyglycosides which can be used according to the invention contain an average of 1.1 to 5 sugar units. Alkyl polyglycosides with x values from 1.1 to 2.0 are preferred. Alkyl glycosides in which x is 1.1 to 1.8 are very particularly preferred.
  • alkoxylated homologs of the alkyl polyglycosides mentioned can also be used according to the invention. These homologues can contain an average of up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.
  • the alkylene oxide adducts with saturated linear fatty alcohols and fatty acids, each with 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid, have proven to be further preferred nonionic surfactants. Preparations with excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants. These connections are characterized by the following parameters.
  • the alkyl radical R contains 6 to 22 carbon atoms and can be either linear or branched. Primary linear and methyl-branched aliphatic radicals in the 2-position are preferred.
  • alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl.
  • 1-Octyl, 1-decyl, 1-lauryl, 1-myristyl are particularly preferred.
  • the compounds with alkyl groups used as surfactant can each be uniform substances. However, it is generally preferred to start from natural vegetable or animal raw materials in the production of these substances, so that substance mixtures with different alkyl chain lengths depending on the respective raw material are obtained.
  • both products with a "normal” homolog distribution and those with a narrowed homolog distribution can be used.
  • “Normal” homolog distribution is understood to mean mixtures of homologues which are obtained as catalysts when fatty alcohol and alkylene oxide are reacted using alkali metals, alkali metal hydroxides or alkali metal alcoholates.
  • narrow homolog distributions are obtained if, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with a narrow homolog distribution can be preferred.
  • the surfactants are used in amounts of 0.1-45% by weight, preferably 1-30% by weight and very particularly preferably 1-15% by weight, based on the total agent.
  • Shampoos according to the invention contain the further cleaning components of the shampoos according to the invention preferably in amounts of from 5.0 to 40% by weight, in particular from 5.0 to 20% by weight, based on the particular preparation.
  • Preparations of particularly great mildness are obtained if, in addition to the surfactants (A), a zwitterionic surfactant, in particular of the betaine type, is used.
  • Anionic and / or nonionic surfactants can then be added as further surfactants.
  • Nonionic surfactants in particular of the alkyl glycoside type, have proven to be outstandingly suitable according to the invention.
  • the agents according to the invention preferably also contain at least one organic thickener.
  • Such thickeners are, for example, thickeners such as agar, guar gum, alginates, cellulose ethers, gelatin, pectins and / or xanthan gum.
  • Ethoxylated fatty alcohols in particular those with limited homolog distribution as they are, for example, as a commercial product under the name Arlypon ® F (Henkel) on the market, alkoxylated methyl glucoside, such as the product Glucamate ® DOE 120 (Amerchol), and ethoxylated Propylenglykolester, such as the product Antil ® 141 (Goldschmidt) can be preferred organic thickeners.
  • the effect can be increased further using polymers.
  • Polymers are understood to mean both natural and synthetic polymers which can be anionic, cationic, amphoteric or non-ionic.
  • Cationic polymers are understood to mean polymers which have groups in the main and / or side chain which can be “temporary” or “permanent” cationic.
  • "permanently cationic” means those polymers which have a cationic group regardless of the pH of the agent. These are generally polymers which contain a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups In particular those polymers in which the quaternary Ammonium group via a C-hydrocarbon group to a polymer main chain composed of acrylic acid, methacrylic acid or their derivatives have been found to be particularly suitable.
  • R -H or -CH 3
  • R ', R "and R'” are independently selected from C-alkyl, alkenyl or hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n a natural number
  • X is a physiologically compatible organic or inorganic anion
  • copolymers consisting essentially of these monomer units and nonionic monomer units are particularly suitable cationic polymers.
  • Suitable physiologically compatible counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions.
  • halide ions in particular chloride, are preferred.
  • a particularly suitable homopolymer is, if desired crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37.
  • the crosslinking can be carried out with the aid of polyolefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylene bisacrylamide, diallyl ether, polyallyl polyglyceryl ether, or AUyl ether of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylene bisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content below 30% by weight.
  • a non-aqueous polymer dispersion which should not have a polymer content below 30% by weight.
  • Such polymer dispersions are available under the names Salcare ® SC 95 (approx. 50% polymer content, further components: mineral oil (TNCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene ether (INCI name: PPG-1-Trideceth- 6)) and Salcare ® SC 96 (approx.
  • Copolymers preferably contain acrylamide, methacrylamide, C- M alkyl acrylate and C-alkyl methacrylate as non-ionic monomer units.
  • acrylamide is particularly preferred.
  • these copolymers can also be crosslinked.
  • a preferred copolymer according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • Celquat ® and Polymer JR ® Quaternized cellulose derivatives, as are commercially available under the names Celquat ® and Polymer JR ® .
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives,
  • honey for example the commercial product Honeyquat ® 50,
  • cationic guar derivatives such as, in particular, the products sold under the trade names Cosmedia ® Guar and Jaguar ® ,
  • Products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning ® 929 emulsion (containing a hydroxylamino modified silicone, which is also known as amodimethicone), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt; diquaternary polydimethylsiloxanes, Quaternium-80 ), - polymeric Dimemyldiallylammoniumsalze and their copolymers with esters and amides of acrylic acid and methacrylic acid.
  • Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate such as, for example, vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers quaternized with diethyl sulfate.
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially, vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ® FC 370, FC 550, FC 905 and HM 552nd quaternized polyvinyl alcohol, as well as those under the names
  • Polyquaternium 27 known polymers with quaternary nitrogen atoms in the main polymer chain.
  • cationic polymers of the invention are the "temporarily cationic" polymers. These polymers usually contain an amino group present at certain pH values as a quaternary ammonium group and thus cationic are preferred, for example, chitosan and its derivatives, such as, for example, under the trade designations Hydagen ®. CMF, Hydagen ® HCMF, Kytamer ® PC and Chitolam ® NB / 101 are freely available commercially Chitosans are deacetylated chitins which are commercially available in different degrees of deacetylation and different degrees of degradation (molecular weights) .They are produced, for example, in DE 44 40 625 AI and described in DE 1 95 03 465 AI.
  • Chitosans which are particularly suitable have a degree of deacetylation of at least 80% and a molecular weight of 5 ⁇ 10 5 to 5 ⁇ 10 6 (g / mol).
  • the chitosan must be converted into the salt form. This can be done by dissolving in dilute aqueous acids.
  • Mineral acids such as e.g. Hydrochloric acid, sulfuric acid and phosphoric acid as well as organic acids, e.g. low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids are suitable.
  • Higher molecular weight alkyl sulfonic acids or alkyl sulfuric acids or organophosphoric acids can also be used, provided that they have the required physiological compatibility.
  • Suitable acids for converting the chitosan to the salt form are e.g.
  • Low molecular weight hydroxycarboxylic acids such as e.g. Glycolic acid or lactic acid is used.
  • the anionic polymers are polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers can consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups can be wholly or partly as sodium, potassium, ammonium, mono- or Triethanolammonium salt are present.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer have proven to be very particularly effective, it being possible for the sulfonic acid group to be present in whole or in part as the sodium, potassium, ammonium, mono- or triethanolammonium salt .
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid is obtainable for example under the name Rheothik ® 11-80 commercially.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are preferred.
  • anionic monomers reference is made to the substances listed above.
  • Preferred nonionic monomers are acrylamide, methacrylamide, acrylic acid ester, methacrylic acid ester, vinyl pyrrolidone, vinyl ether and vinyl ester.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with monomers containing sulfonic acid groups.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, the sulfonic acid group being wholly or partly as sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer can also be crosslinked, with polyolefinically unsaturated compounds such as tetraallyloxyethane, AUylsucrose, allylpentaerythritol and methylene bisacrylamide preferably being used as crosslinking agents.
  • polyolefinically unsaturated compounds such as tetraallyloxyethane, AUylsucrose, allylpentaerythritol and methylene bisacrylamide preferably being used as crosslinking agents.
  • polyolefinically unsaturated compounds such as tetraallyloxyethane, AUylsucrose, allylpentaerythritol and methylene bisacrylamide preferably being used as crosslinking agents.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • the use of this compound which in addition to the polymer component, a hydrocarbon mixture (C, 3 -C 14 is
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene can be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether are also color-preserving polymers.
  • a cross-linked with 1,9-decadiene maleic acid-methyl vinyl ether copolymer is available under the name Stabileze® ® QM.
  • amphoteric polymers can be used as polymers in the agents according to the invention.
  • amphoteric polymers includes both those polymers which contain both free amino groups and free -COOH or SO 3 H groups in the molecule and are capable of forming internal salts, and also zwitterionic polymers which contain quaternary ammonium groups and -COO in the molecule " - or -SO 3 * groups, and summarized such polymers that contain -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphopolymer suitable is that available under the name Amphomer ® acrylic resin which is a copolymer of tert-butylaminoethyl methacrylate, N- (1,1,3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group of acrylic acid, Methacrylic acid and its simple esters.
  • Further amphoteric polymers which can be used according to the invention are those in British Offenlegungsschrift 2 104 091, European Offenlegungsschrift 47 714, the European laid-open specification 217 274, European laid-open specification 283 817, German laid-open specification 28 17 369 and in particular the compounds mentioned in German laid-open specification 39 29 973.
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / Ninylester copolymers as are marketed, for example under the trademark Luviskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALO ⁇ ).
  • the preparations used contain several, in particular two different polymers of the same charge and / or each contain an ionic and an amphoteric and / or non-ionic polymer.
  • polymer is also to be understood as meaning special preparations of polymers, such as spherical polymer powders.
  • Various methods are known for producing such microspheres from different monomers, for example by special polymerization processes or by dissolving the polymer in a solvent and spraying it into a medium in which the solvent can evaporate or diffuse out of the particles.
  • Suitable polymers are, for example, polycarbonates, polyurethanes, polyacrylates, polyolefins, polyesters or polyamides.
  • Spherical polymer powders whose primary particle diameter is less than 1 ⁇ m are particularly suitable.
  • Such products based on a polymethacrylate copolymer are, for example, under the trademark Polytrap ® Q5- 6603 (Dow Corning).
  • Other polymer powders e.g. based on polyamides (nylon 6, nylon 12) are available with a particle size of 2 - 10 ⁇ m (90%) and a specific surface area of approx. 10 m 2 / g under the trade name Orgasol ® 2002 DU Nat Cos ( Atochem SA, Paris) available.
  • spherical polymer powders which are suitable for the purpose according to the invention are, for example, the polymethacrylates (Micropearl M) from SEPPIC or (Plastic Powder A) from NIKKOL, the styrene-divinylbenzene copolymers (Plastic Powder FP) from NIKKOL, the polyethylene and polypropylene - Powder (ACCUREL EP 400) from AKZO, or also silicone polymers (Silicone Powder X2-1605) from Dow Corning or spherical cellulose powder.
  • the polymethacrylates (Micropearl M) from SEPPIC or (Plastic Powder A) from NIKKOL
  • Plastic Powder FP styrene-divinylbenzene copolymers
  • ACCUREL EP 400 polyethylene and polypropylene - Powder
  • silicone polymers Silicone Powder X2-1605
  • the polymers are contained in the agents used according to the invention preferably in amounts of 0.01 to 10% by weight, based on the total agent. Amounts from 0.1 to 5, in particular from 0.1 to 3% by weight are particularly preferred.
  • Hair treatment agents can be, for example, shampoos, hair rinses, hair treatments, permanent waving agents (wave lotions, fixatives), hair colorants, hair tinting agents, hair setting agents, hair sprays, hair lotions or hair tip fluids.
  • the preparations can be formulated as solutions, emulsions, gels, creams, aerosols or lotions; they can remain on the hair or, after a short exposure time, which can be preferred, rinsed out again.
  • the amount of dissolved inorganic salts is limited to less than 2% by weight, in particular less than 0.5% by weight. It should also be noted that such salts are not only e.g. to adjust the viscosity, but can also be introduced by other active ingredients, in particular surfactants.
  • compositions such as lactic acid and maleic acid
  • hair-conditioning compounds such as phospholipids, for example soy lecithin
  • Perfume oils especially those with the fragrance of a fruit, such as apple, pear, strawberry, peach, apricot, pineapple, banana, cherry, kiwi,
  • Fragrance note of a luxury food such as tobacco, cola, chewing gum,
  • Solubilizers such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerin, diethylene glycol and ethoxylated triglycerides,
  • Anti-dandruff agents such as climbazole, piroctone olamine and zinc omadine,
  • Active ingredients such as bisabolol, allantoin and plant extracts, fiber structure-improving active ingredients, in particular mono-, di- and oligosaccharides such as glucose, galactose, fructose, fructose and lactose, vitamins, provitamins and vitamin precursors, in particular of groups A, B, C, E,
  • Ncotinamide and biotin quaternized amines such as methyl l-alkylamidoethyl-2-alkylimidazolinium methosulfate,
  • Light stabilizers in particular derivatized benzophenones, cinnamic acid derivatives and
  • Ceramides include N-acylsphingosine (fatty acid amides of
  • Consistency enhancers such as sugar esters, polyol esters or polyol alkyl ethers,
  • Swelling and penetration substances such as PCA, glycerin, propylene glycol monoethyl ether,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescent agents such as ethylene glycol mono- and distearate or PEG-3 distearate, direct dyes, so-called coupler and developer components as oxidation dye precursors,
  • Reducing agents such as Thioglycolic acid and its derivatives, thiolactic acid, cytamine, thio malic acid and ⁇ -mercaptoethanesulfonic acid,
  • Oxidizing agents such as hydrogen peroxide, potassium bromate and sodium bromate
  • Blowing agents such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air as well
  • the active ingredient according to the invention is applied to the keratin fiber, in particular human hair, and to the skin.
  • preparations include, for example, creams, lotions, solutions, water, emulsions such as W / O, O / W, PIT emulsions (emulsions based on the teaching of phase inversion, PIT), microemulsions and multiple emulsions, coarse, unstable, single or multi-phase shake mixes, gels, sprays, aerosols and foam aerosols are suitable.
  • emulsions such as W / O, O / W
  • PIT emulsions emulsions based on the teaching of phase inversion, PIT
  • microemulsions and multiple emulsions coarse, unstable, single or multi-phase shake mixes
  • gels, sprays, aerosols and foam aerosols are suitable.
  • These are in usually formulated on an aqueous or aqueous-alcoholic basis.
  • Lower alkanols and polyols such as propylene glycol and glycerol are used as the alcoholic component.
  • Ethanol and isopropanol are preferred alcohols.
  • Water and alcohol can be present in the aqueous alcoholic base in a weight ratio of 1:10 to 10: 1.
  • Water and aqueous-alcoholic mixtures which contain up to 50% by weight, in particular up to 25% by weight, of alcohol, based on the alcohol / water mixture, can be preferred bases according to the invention.
  • microemulsions are also understood to mean so-called “PIT” emulsions.
  • PIT phase inversion temperature
  • these emulsions are systems with the 3 components water, oil and emulsifier, which at room temperature act as oil-in-water (O / W).
  • O / W oil-in-water
  • PIT phase inversion temperature
  • microemulsions are again formed, but these are also present at room temperature as microemulsions with an average particle diameter of less than 400 nm, in particular with a particle diameter of about 100-300 nm.
  • PIT emulsions Details regarding these very stable, low-viscosity systems, for which the term “PIT emulsions” has generally become established, can be found in a large number of publications, for which the publications in Angew. Chem. 97, 655-669 (1985) are representative. and Adv. Colloid Interface Sei 58, 119-149 (1995) According to the invention, those micro- or "PIT" emulsions can be preferred which have an average particle diameter of about 200 nm.
  • the microemulsions according to the invention can be prepared, for example, by first determining the phase inversion temperature of the system by heating a sample of the emulsion prepared in the customary manner and using a conductivity meter to determine the temperature at which the conductivity decreases sharply.
  • the decrease in specific conductivity initially Existing O / W emulsion generally decreases over a temperature range of 2 to 8 ° C from originally more than 1 mS / cm to values below 0.1 mS / cm. This temperature range then corresponds to the phase inversion temperature range.
  • the emulsion initially prepared as usual, from the oil component, nonionic emulsifier, at least parts of the water and optionally further components can be heated to a temperature which is within or above the phase inversion temperature range, then cooled and optionally add other components as well as the remaining water.
  • the microemulsion can also be produced directly at a temperature which is within or above the phase inversion temperature range. The microemulsion thus produced is then cooled to a temperature below the phase inversion temperature range, usually room temperature.
  • the invention also relates to the use of an agent according to one of claims 1 to 16 for cleaning skin and hair.
  • N, N-Dimethyl-N-coconut amidopropylammonium acetobetaine (approx. 30% active substance in water; INCI name: Cocamidopropyl betaine) (CLARIANT) N-coconut fatty acid amidoethyl-N-2-hydroxyethylglycine sodium salt (approx. 50% active substance in water; INCI name : Disodium Cocoamphodiacetate) (WITCO) neutralized ester of alkyl polyglucose with tartaric acid (approx. 30% active substance in water; INCI name (provisional): Sodium Cocopolyglucose Tartrate) (CESALPINIA) neutralized ester of alkyl polyglucose with citric acid (approx. 30% active substance in water ; rNCI name (provisional): Sodium Cocopolyglucose Citrate) (CESALPINIA)
  • Hexamethyldisiloxane (INCI name: Dimethicone) (DOW CORNING) quaternized wheat protein hydrolyzate (approx. 33% active substance in water; INCI name: Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein) (GRÜNAU)
  • Wheat protein hydrolyzate fatty acid condensate (approx. 33% active substance in water; INCI name: Sodium Cocoyl Hydrolyzed Wheat Protein) (GRÜNAU) N, N-Dimemyl-N- (2-hydroxyethyl) -N- (2-hydroxyhexadecyl) ammonium chloride (approx.
  • COGNIS Hydroxycetyl Hydroxyethal Dimonium Chloride
  • COGNIS C16-18 fatty alcohol
  • COGNIS Cetearyl Alcohol
  • Amphoteric surfactant-pearlescent mixture based on plants INCI name: Aqua, Glycol Distearate, Glycerin, Laureth-4, Cocamidopropyl Betaine, Formic Acid) (COGNIS)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des agents cosmétiques aqueux pour traiter les cheveux ou la peau, sur une base tensioactive douce, qui contiennent : comme tensioactif, au moins un ester d'acide bi- ou tricarboxylique (A) substitué par hydroxy de formule générale (I) dans laquelle X désigne H ou un groupe CH2COOR, Y désigne H ou OH à condition que Y désigne H, si X désigne CH2COOR, R,R1 et R2 désignent indépendamment les uns des autres, un atome d'hydrogène, un cation de métal alcalin ou alcalino-terreux, un groupe ammonium, le cation d'une base ammonium organique ou un reste Z issu d'un composé organique polyhydroxylé, sélectionné dans le groupe comprenant des (C¿6?-C18)-alkyle-polysaccharides éthérifiés ayant entre 2 et 16 unités saccharide monomères et des (C6-C16)-hydroxyalykle-polyols aliphatiques éthérifiés ayant entre 2 et 16 restes hydroxyle, à condition qu'au moins un des groupes R,R?1 ou R2¿ désigne un reste Z, et au moins une substance traitante (B) sélectionnée parmi des hydrolysats de protéine et leurs dérivés (B1), des composés ammonium quaternaires (B2), des composés silicone non solubles (B3) et des constituants huileux, gras ou cireux synthétiques ou naturels (B4). Ces agents se caractérisent en ce qu'ils sont exceptionnellement doux et présentent des propriétés traitantes remarquables.
PCT/EP2000/003195 1999-04-12 2000-04-11 Agent cosmetique et son utilisation WO2000061066A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU41170/00A AU4117000A (en) 1999-04-12 2000-04-11 Cosmetic product and its use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19916335A DE19916335A1 (de) 1999-04-12 1999-04-12 Kosmetisches Mittel und Verwendung
DE19916335.9 1999-04-12

Publications (2)

Publication Number Publication Date
WO2000061066A2 true WO2000061066A2 (fr) 2000-10-19
WO2000061066A3 WO2000061066A3 (fr) 2001-02-22

Family

ID=7904208

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2000/002967 WO2000061099A1 (fr) 1999-04-12 2000-04-04 Agent cosmetique aqueux contenant des esters d'acide tartrique ou d'acide citrique d'alkylpolyglycoses et un principe actif acide ayant des proprietes de conservation
PCT/EP2000/003195 WO2000061066A2 (fr) 1999-04-12 2000-04-11 Agent cosmetique et son utilisation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/002967 WO2000061099A1 (fr) 1999-04-12 2000-04-04 Agent cosmetique aqueux contenant des esters d'acide tartrique ou d'acide citrique d'alkylpolyglycoses et un principe actif acide ayant des proprietes de conservation

Country Status (3)

Country Link
AU (2) AU4542300A (fr)
DE (1) DE19916335A1 (fr)
WO (2) WO2000061099A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283033A1 (fr) * 2001-07-24 2003-02-12 Cs Association d'alkylglycoside et de pyridinecarboxamide
EP1555010A1 (fr) * 2003-12-18 2005-07-20 Beiersdorf AG Composition nettoyante cosmétique ayant des propriétés de soin améliorées.
US7087560B2 (en) 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
US7176172B2 (en) 2004-10-25 2007-02-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Quaternary ammonium polyol salts as anti-aging actives in personal care compositions
US7282471B2 (en) 2005-09-08 2007-10-16 Conopco, Inc. Personal care compositions with glycerin and hydroxypropyl quaternary ammonium salts
US7659234B2 (en) 2006-03-07 2010-02-09 Conopco, Inc. Personal care compositions containing quaternary ammonium trihydroxy substituted dipropyl ether
US7659233B2 (en) 2004-10-25 2010-02-09 Conopco, Inc. Personal care compositions with silicones and dihydroxypropyl trialkyl ammonium salts
US7794741B2 (en) 2007-05-30 2010-09-14 Conopco, Inc. Enhanced delivery of certain fragrance components from personal care compositions
US8124063B2 (en) 2004-10-25 2012-02-28 Conopco, Inc. Method for moisturizing human skin using dihydroxypropyltri(C1-C3 alkyl) ammonium salts

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005013489A1 (de) * 2005-03-21 2006-09-28 Henkel Kgaa Haarreinigungsmittel mit optimiertem Fließverhalten
DE102007037122A1 (de) 2007-08-01 2009-02-05 Beiersdorf Ag Haarbehandlungsmittel mit einem Gehalt an Diamanten
DE102007050371A1 (de) 2007-10-17 2009-04-23 Beiersdorf Ag Haarbehandlungsmittel VII
EP2198850A1 (fr) * 2008-12-22 2010-06-23 L'oreal Composition cosmétique détergente comprenant quatre tensioactifs et un corps gras non siliconé
FR2940071A1 (fr) * 2008-12-22 2010-06-25 Oreal Composition cosmetique detergente comprenant quatre tensioactifs et un corps gras solide
FR2940072B1 (fr) * 2008-12-22 2011-03-11 Oreal Composition cosmetique detergente comprenant quatre tensioactifs et un corps gras liquide non silicone
AU2010357689B2 (en) * 2010-07-19 2014-06-12 Colgate-Palmolive Company Cleansing composition with decyl and coco glucosides
US10987292B2 (en) 2013-11-11 2021-04-27 Colgate-Palmolive Company Preservative system
US11096878B2 (en) 2018-05-31 2021-08-24 L'oreal Concentrated rinse-off cleansing composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247517B (it) * 1991-04-24 1994-12-17 Auschem Spa Procedimento per la preparazione di tensioattivi derivati da acidi di- o tri-carbossilici
ATE147258T1 (de) * 1992-09-29 1997-01-15 Henkel Kgaa Haarnachbehandlungsmittel
MX9703824A (es) * 1994-11-23 1998-02-28 Colgate Palmolive Co Composiciones limpiadoras liquidas para trabajos ligeros en forma de microemulsion.
FR2785800B1 (fr) * 1998-11-12 2002-11-29 Oreal Compositions cosmetiques contenant un tensioactif d'alkylpolyglycoside anionique, une gomme de galactomannane et leurs utilisations
FR2785797B1 (fr) * 1998-11-12 2002-10-18 Oreal Compositions cosmetiques contenant un tensioactif ester d'alkylpolyglycoside anionique et un agent conditionneur liquide insoluble dans l'eau et leurs utilisations

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283033A1 (fr) * 2001-07-24 2003-02-12 Cs Association d'alkylglycoside et de pyridinecarboxamide
EP1555010A1 (fr) * 2003-12-18 2005-07-20 Beiersdorf AG Composition nettoyante cosmétique ayant des propriétés de soin améliorées.
US7087560B2 (en) 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
US7176172B2 (en) 2004-10-25 2007-02-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Quaternary ammonium polyol salts as anti-aging actives in personal care compositions
US7659233B2 (en) 2004-10-25 2010-02-09 Conopco, Inc. Personal care compositions with silicones and dihydroxypropyl trialkyl ammonium salts
US8124063B2 (en) 2004-10-25 2012-02-28 Conopco, Inc. Method for moisturizing human skin using dihydroxypropyltri(C1-C3 alkyl) ammonium salts
US7282471B2 (en) 2005-09-08 2007-10-16 Conopco, Inc. Personal care compositions with glycerin and hydroxypropyl quaternary ammonium salts
US7659234B2 (en) 2006-03-07 2010-02-09 Conopco, Inc. Personal care compositions containing quaternary ammonium trihydroxy substituted dipropyl ether
US7794741B2 (en) 2007-05-30 2010-09-14 Conopco, Inc. Enhanced delivery of certain fragrance components from personal care compositions

Also Published As

Publication number Publication date
WO2000061066A3 (fr) 2001-02-22
DE19916335A1 (de) 2000-10-19
AU4542300A (en) 2000-11-14
AU4117000A (en) 2000-11-14
WO2000061099A1 (fr) 2000-10-19

Similar Documents

Publication Publication Date Title
EP2328544B1 (fr) Composition à base de tensioactifs contenant un mélange d'émulsifiants spécial
DE10022077A1 (de) Kosmetisches Mittel enthaltend 2-Furanonderivate
WO1994007458A1 (fr) Combinaison d'un shampoing/apres-shampoing
WO2000061066A2 (fr) Agent cosmetique et son utilisation
EP1179339B1 (fr) Produit cosmétique contenant des extraits de graines de "malvaceae"
EP2020227B1 (fr) Dérivés de cellulose cationiques en cosmétique
EP1404286B1 (fr) Agent de soin capillaire comprenant un tartrate de carnitine
EP1779845B1 (fr) Utilisation de dérivés de cellulose cationiques en cosmétique
EP1838833B1 (fr) Nettoyant tensioactif comprenant des proteines specifiques
WO2004028495A1 (fr) Soin pour les cheveux comprenant une combinaison de substances actives aux liposomes
EP1302191B1 (fr) Composition moussante pour le soin de la chevelure
EP1430884B1 (fr) Huile de bain-douche avec une combinaison tensioactive particulière
EP1675564A1 (fr) Produits contenant de la valeriane
DE19941819A1 (de) Kosmetisches Mittel
DE102009045856A1 (de) Verwendung kationischer Polymere in Haut- und Haarreinigungsmitteln
DE102009026775A1 (de) Tensidhaltiges kosmetisches Reinigungsmittel mit Gelee Royale
EP1634565B1 (fr) Composition exfoliante pour le corps
EP3337570B1 (fr) Shampooing de conditionnement avec mélange d'ester d'huiles végétales
DE19717687A1 (de) Zubereitung zur Behandlung keratinischer Fasern
WO2008031685A1 (fr) Extrait de racine issu de harpagophytum pour stimuler la pousse des cheveux
DE19916334A1 (de) Kosmetisches Mittel und Verwendung
DE102006042232A1 (de) Biochinone zur Stimulierung der Keratinsynthese
DE102009028085A1 (de) Verwendung von Olivenöl und Proteinhydrolysaten in der Haarpflege
DE102009045605A1 (de) Versprühbares Haarreinigungsmittel
DE10064634A1 (de) Kosmetische Mittel enthaltend Malvaceae-Samenextrakte

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR BY CA CN CZ HU JP KR NZ PL RU SI SK US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR BY CA CN CZ HU JP KR NZ PL RU SI SK US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载